Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
about
Molecular mechanisms for adaptive tolerance and other T cell anergy modelsSLE-associated risk factors affect DC functionInduced regulatory T cells: mechanisms of conversion and suppressive potentialT-regulatory cells in primary immune deficienciesRegulatory cells and transplantation toleranceCTLA-4 blockade in tumor models: an overview of preclinical and translational researchTGF-beta: a mobile purveyor of immune privilegeIndoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethalityVirus Infections Incite Pain Hypersensitivity by Inducing Indoleamine 2,3 DioxygenaseImmunosuppressive strategies that are mediated by tumor cellsDevelopment of murine lupus involves the combined genetic contribution of the SLAM and FcgammaR intervals within the Nba2 autoimmune susceptibility locus.IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes.Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases.Interactions between Th1 cells and Tregs affect regulation of hepatic fibrosis in biliary atresia through the IFN-γ/STAT1 pathway.A randomized controlled trial to evaluate inhibition of T-cell costimulation in allergen-induced airway inflammation.Th17 cells and regulatory T cells in elite control over HIV and SIV.B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenaseCellular mechanisms of the adjuvant activity of the flagellin component FljB of Salmonella enterica Serovar Typhimurium to potentiate mucosal and systemic responses.Airway epithelial indoleamine 2,3-dioxygenase inhibits CD4+ T cells during Aspergillus fumigatus antigen exposure.Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn's disease.Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.Curcumin suppresses the induction of indoleamine 2,3-dioxygenase by blocking the Janus-activated kinase-protein kinase Cdelta-STAT1 signaling pathway in interferon-gamma-stimulated murine dendritic cells.Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators.An evolving perspective about the origins of childhood undernutrition and nutritional interventions that includes the gut microbiome.Amino acid catabolism: a pivotal regulator of innate and adaptive immunity.Tolerogenic dendritic cells and their role in transplantation.Dietary ligands of the aryl hydrocarbon receptor induce anti-inflammatory and immunoregulatory effects on murine dendritic cells.The role of pDC, recipient T(reg) and donor T(reg) in HSC engraftment: Mechanisms of facilitation.IDO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated Ag-4 Ig-mediated long-term solid organ allograft survival.Expression of the Kynurenine Pathway in Human Peripheral Blood Mononuclear Cells: Implications for Inflammatory and Neurodegenerative DiseaseThe role of indoleamine 2, 3 dioxygenase in regulating host immunity to leishmania infectionInhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitisThe role of coinhibitory signaling pathways in transplantation and toleranceAltered tryptophan metabolism as a paradigm for good and bad aspects of immune privilege in chronic inflammatory diseases.The battle against immunopathology: infectious tolerance mediated by regulatory T cells.Apicomplexan parasite, Eimeria falciformis, co-opts host tryptophan catabolism for life cycle progression in mouseInduction of indoleamine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection.Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors.
P2860
Q24671646-20257488-0388-411C-9D6B-8F8C338F2D36Q26774797-980FC58B-4661-4F84-8AE9-0C0ADFA1C292Q26823869-08DB5599-81EA-41CA-88DA-01F0789B9025Q26862699-D4BB696B-0874-43C2-AFDD-45CAE2F0A158Q26865816-E85244AF-4DB2-45E2-9BB6-0F9C5ED6978AQ26992295-20CD3D6C-EAFB-4949-819F-EB335C8D25F7Q28263622-916BDD5A-E969-4E19-A0DC-7C6D0A2E7A5DQ28509235-099B708B-A4BA-4DA1-A3F6-F08C6B1379CCQ28551939-A33A978C-ED83-406A-B308-558BFEFA4BE9Q29636247-53B6A6B6-9E1C-46C6-9DFC-8E64FE21D523Q30433488-2FBBD44F-CFC7-479C-A11F-1284DA0F2986Q33382323-50F9F874-7EE8-47D7-B837-1443337B9DDFQ33718865-E81CEB74-330C-455F-AEAB-ECE028551C7CQ33721369-EA6C14E7-C60F-44E6-97F1-7440CE02FE7CQ33738516-61BA14F4-A740-41FD-939E-8D00862630F4Q33838915-15CCF320-B925-4A0D-8D08-202120F4315DQ33934819-49628826-0977-4634-A3B7-7085DA8BFA65Q34033524-17AC461A-49F6-4210-9157-5EA77BD0F0DEQ34526556-17CA6A77-CA9D-42E7-BD2A-133937FF3E6BQ34601368-523C7291-52A4-48B2-BABC-3552EC8738E7Q34650346-1623C00C-E37A-4511-917B-7C503AA5BB2FQ34655953-51594E2A-D3E6-4FCC-9C8D-8B15E50863BCQ34657500-3E9BC1CD-542F-4FD1-91A9-EFE00A9FDCCDQ34657796-83245D55-7B93-4735-921A-60BA9680D4B1Q34707334-1075ECCC-DB62-4DD1-B9BE-57A7FCDE13B4Q35223836-6C18E9E3-9E63-46B8-86A9-BE406C224127Q35261125-A447E82D-B700-4BB1-BB84-CB12A4BFD506Q35341379-F21F879A-03C6-41F8-BDA0-AC3D927A8650Q35551015-8D26C821-0258-48BB-B7C5-F48BB9028FECQ35603220-F1A1588A-1A1C-4EFD-8C11-98650760FCEEQ35645172-6F5D834E-84AF-4F81-AE3A-1E95D24A1A44Q35788146-4F3ACBB1-B44B-4B3C-8DE0-90DD9ED24C5BQ35808796-CB043757-5A57-4254-B1D8-491C0FE9BA7FQ35848218-269644B6-6B50-44C6-9A16-10B0DA8C49CCQ35928357-F4F54F2E-30C6-45E2-99E5-31F7C3F2B12DQ35952614-E38C83A8-3F79-4ED7-9124-C4C43692D55AQ35962634-63700F2E-318C-4E98-93C8-A6D2D61A176DQ36016868-0617A668-0AC8-4ECF-B763-393FE5DF4B3DQ36154064-7A88A563-9F11-4B38-854C-2DBF62F2A87CQ36219738-FF845310-6798-4B5A-89E5-7E9DE88DCCAA
P2860
Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Specific subsets of murine den ...... f indoleamine 2,3 dioxygenase.
@en
Specific subsets of murine den ...... f indoleamine 2,3 dioxygenase.
@nl
type
label
Specific subsets of murine den ...... f indoleamine 2,3 dioxygenase.
@en
Specific subsets of murine den ...... f indoleamine 2,3 dioxygenase.
@nl
prefLabel
Specific subsets of murine den ...... f indoleamine 2,3 dioxygenase.
@en
Specific subsets of murine den ...... f indoleamine 2,3 dioxygenase.
@nl
P2093
P356
P1476
Specific subsets of murine den ...... f indoleamine 2,3 dioxygenase.
@en
P2093
Andrew L Mellor
Anna M Hansen
Babak Baban
Brendan Marshall
David H Munn
Elizabeth Adams
Jeanene Pihkala
Phillip Chandler
P304
P356
10.1093/INTIMM/DXH140
P577
2004-09-06T00:00:00Z